Standard BioTools Inc (NAS:LAB)
$ 1.82 -0.08 (-4.21%) Market Cap: 707.29 Mil Enterprise Value: 404.38 Mil PE Ratio: 0 PB Ratio: 1.45 GF Score: 51/100

Standard BioTools Inc at Cowen Health Care Conference Transcript

Mar 08, 2023 / 05:50PM GMT
Release Date Price: $2.24 (+3.23%)
Daniel Brennan
TD Cowen - Analyst

Welcome here to our last day of TD Cowen Healthcare Conference. Really pleased to be joined with me the CEO of Standard BioTools, Michael Egholm. Am I pronouncing it right?

Michael Egholm
Standard BioTools, Inc. - President and CEO

Close enough.

Daniel Brennan
TD Cowen - Analyst

I apologize. Mike is going to do a presentation for about 15 minutes and then we can have some time for Q&A afterwards.

So with that, Michael, thank you.

Michael Egholm
Standard BioTools, Inc. - President and CEO

Thanks, Dan, and thanks to the Cowen team for the opportunity here to, for the first time, present the Standard BioTools story here, so very, very excited to share our story with you.

I will be making forward-looking statements and require for you to read -- all of you to read this. Okay.

Standard BioTools was founded based on a huge opportunity that we see in the marketplace. The problem we want to solve -- the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot